Cuprina Holdings (Cayman) Limited (CUPR)
NASDAQ: CUPR · Real-Time Price · USD
0.4899
-0.0051 (-1.03%)
Dec 12, 2025, 9:37 AM EST - Market open
CUPR Revenue
Cuprina Holdings (Cayman) Limited had revenue of 23.02K SGD in the half year ending June 30, 2025, a decrease of -48.50%. This brings the company's revenue in the last twelve months to 30.33K, down -68.76% year-over-year. In the year 2024, Cuprina Holdings (Cayman) Limited had annual revenue of 48.32K, down -52.05%.
Revenue (ttm)
30.33K SGD
Revenue Growth
-68.76%
P/S Ratio
445.75
Revenue / Employee
2,167 SGD
Employees
14
Market Cap
10.51M USD
Revenue Chart
* This company reports financials in SGD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.32K | -52.45K | -52.05% |
| Dec 31, 2023 | 100.77K | 44.17K | 78.05% |
| Dec 31, 2022 | 56.60K | -1.91K | -3.26% |
| Dec 31, 2021 | 58.50K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCUPR News
- 14 days ago - Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 6 weeks ago - Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies - GlobeNewsWire
- 2 months ago - Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET - GlobeNewsWire
- 3 months ago - Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology - GlobeNewsWire
- 4 months ago - Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets - Benzinga
- 5 months ago - Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market - GlobeNewsWire
- 5 months ago - Cuprina Provides Update on Research Studies with Three Leading Education Institutes - GlobeNewsWire
- 6 months ago - Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries - GlobeNewsWire